missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mouse CHL-1/L1CAM-2 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 12 publications
Brand: R&D Systems AF2147-SP
This item is not returnable.
View return policy
Description
CHL-1/L1CAM-2 Polyclonal specifically detects CHL-1/L1CAM-2 in Mouse samples. It is validated for Western Blot, Simple Western, Immunohistochemistry.
Specifications
| CHL-1/L1CAM-2 | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CALL, CALLClose homolog of L1, cell adhesion molecule with homology to L1CAM (close homolog of L1), cell adhesion molecule with homology to L1CAM (close homologue of L1), CHL1, FLJ44930, L1CAM-2, L1CAM2L1 cell adhesion molecule 2, MGC132578, neural cell adhesion molecule L1-like protein | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 10752 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot, Immunohistochemistry | |
| LYOPH | |
| Western Blot 0.25 ug/mL, Simple Western 2.5 ug/mL, Immunohistochemistry 5-15 ug/mL | |
| BAC30699 | |
| CHL1 | |
| Mouse myeloma cell line NS0-derived recombinant mouse CHL-1/L1CAM-2 Ala25-Gln1043 (Leu227-Gln242 del, Ala243Ser) Accession # BAC30699 | |
| 25 μg | |
| Primary | |
| Detects mouse CHL-1/L1CAM-2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 40% cross-reactivity with recombinant human CHL-1 is observed. | |
| Mouse | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction